Hi 12skip,
Personally I think we can take a lot of comfort from the continued importance and emphasis put on 008 by PAR... this while being able to see results of the patients... they would have side stepped from 008 if results to date weren't good...
It's blinded to patients, not to PAR...
Having said that, pain and function alone could still be the maker of an amazing successful company...but, I'm confident in it, and more so par's continued confident language about it...
A most comprehensive exploratory study..., page-8
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.015(7.32%) |
Mkt cap ! $76.98M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 22.5¢ | 21.0¢ | $242.2K | 1.102M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16020 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 310000 | 2 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |